Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges

被引:16
|
作者
Macintyre, Pamela E. [1 ,2 ]
Roberts, Lindy J. [3 ,4 ]
Huxtable, Christine A. [1 ,2 ]
机构
[1] Royal Adelaide Hosp, Dept Anaesthesia Pain Med & Hyperbar Med, Acute Pain Serv, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA 5000, Australia
[3] Sir Charles Gairdner Hosp, Dept Anaesthesia, Nedlands, WA 6009, Australia
[4] Sir Charles Gairdner Hosp, Dept Pain Management, Nedlands, WA 6009, Australia
关键词
TOTAL KNEE ARTHROPLASTY; CHRONIC NONCANCER PAIN; HOSPITAL TRANSITIONAL PAIN; POSTOPERATIVE PAIN; INDUCED HYPERALGESIA; RISK-FACTORS; RESPIRATORY DEPRESSION; EMERGENCY-DEPARTMENT; UNITED-STATES; USE DISORDER;
D O I
10.1007/s40265-019-01236-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For over two decades, dramatic increases in opioid prescriptions in the developed world, especially for long-term management of chronic noncancer pain, were accompanied by increases in patient harm. In recent years in the USA, opioid-related deaths rates have continued to increase despite falls in prescribing rates and deaths associated with prescription opioids. In large part, this is attributed to the growing availability of illicitly manufactured fentanyl. Increased opioid use, for medical and nonmedical reasons, has led to more opioid-tolerant patients requiring management of acute pain. The potential harms associated with long-term opioid use are now well known. What may be less well understood is that preoperative long-term opioid use is associated with increased perioperative complications including infection, readmissions, and greater healthcare utilisation and costs. Minimizing opioid use prior to surgery is a modifiable risk factor that could benefit both patient and healthcare system. Management of acute pain should include simple analgesics and adjuvants, with short-term opioid dose increases if needed and use of non-pharmacological strategies. Reported pain intensities may be high and titration of analgesia to function rather than pain scores is appropriate. Importantly, compared with opioid-naive patients, opioid-tolerant patients may be at higher risk of opioid-induced ventilatory impairment when additional opioids are administered to manage new acute pain. For some patients, perioperative care may be best coordinated by a perioperative or post-discharge service with referral to multidisciplinary pain and addiction medicine services as indicated. Carefully planned and communicated discharge prescribing, with a weaning plan for additional opioids, is essential.
引用
收藏
页码:9 / 21
页数:13
相关论文
共 50 条
  • [31] Postoperative pain management for opioid tolerant patients
    McDonald, D.
    Camilleri, C.
    Davis, D.
    Martin, C.
    JOURNAL OF PAIN, 2013, 14 (04): : S83 - S83
  • [32] Newer Generation Fentanyl Transmucosal Products for Breakthrough Pain in Opioid-Tolerant Cancer Patients
    Frank Elsner
    Giovambattista Zeppetella
    Josep Porta-Sales
    Ignacio Tagarro
    Clinical Drug Investigation, 2011, 31 : 605 - 618
  • [33] Tapentadol is effective in the management of moderate-to-severe cancer-related pain in opioid-naive and opioid-tolerant patients: a retrospective study
    Sazuka, Shoichiro
    Koitabashi, Toshiya
    JOURNAL OF ANESTHESIA, 2020, 34 (06) : 834 - 840
  • [34] Use of Dexmedetomidine for Postoperative Pain Management Following Spine Fusion Surgery in a Highly Opioid-Tolerant Patient
    Wu, Jiang
    Ku, Stephen C.
    Ko, Andrew L.
    JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2019, 33 (1-2) : 49 - 53
  • [35] Low-Dose Ketamine Infusions for Postoperative Pain in Opioid-Tolerant Orthopaedic Spine Patients
    Farrington, Michele
    Hanson, Allison
    Laffoon, Trudy
    Cullen, Laura
    JOURNAL OF PERIANESTHESIA NURSING, 2015, 30 (04) : 338 - 345
  • [36] Fentanyl Buccal Tablet in Breakthrough Pain in Opioid-Tolerant Patients with CancerA Viewpoint by Sebastiano Mercadante
    Sebastiano Mercadante
    Drugs, 2006, 66 : 2394 - 2395
  • [37] Efficacy and tolerability of fentanyl buccal tablet (FBT) in opioid-tolerant cancer patients with neuropathic pain
    Thakur, R.
    Vaughan, J. A.
    Messina, J.
    Xie, F.
    Taylor, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] The Efficacy and Safety of Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain
    Ashburn, Michael A.
    Slevin, Kieran A.
    Messina, John
    Xie, Fang
    ANESTHESIA AND ANALGESIA, 2011, 112 (03): : 693 - 702
  • [39] Tapentadol is effective in the management of moderate-to-severe cancer-related pain in opioid-naïve and opioid-tolerant patients: a retrospective study
    Shoichiro Sazuka
    Toshiya Koitabashi
    Journal of Anesthesia, 2020, 34 : 834 - 840
  • [40] Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain
    Harold Minkowitz
    Janet Bull
    R. Charles Brownlow
    Neha Parikh
    Richard Rauck
    Supportive Care in Cancer, 2016, 24 : 2669 - 2675